Sharp Sterile Manufacturing Announces $28M Investment to Expand Lee Facility
Introduction
Sharp Sterile Manufacturing has announced a $28 million expansion of its Lee, Massachusetts site, aiming to increase production capacity and support local skilled jobs in the life sciences sector. The investment marks a significant step in the company’s ongoing growth.
Features
The expansion will more than double the facility’s filling capacity with the addition of a fully automated IMA Life isolated filling line for ready-to-use vials.
The new system uses advanced robotics, non-destructive weight checks, and a modern lyophiliser, allowing production of batches of up to 100,000 units.
These improvements will increase throughput, helping pharmaceutical partners deliver critical treatments to patients more quickly.
The facility will also be upgraded to meet the highest regulatory standards for sterile drug manufacturing, ensuring quality and safety remain paramount.
The expansion underlines Sharp Sterile’s focus on advanced technology, local employment, and supporting the growing demand for U.S.-based sterile pharmaceutical manufacturing.
Specifications
| Name | Sharp Sterile Manufacturing |
| Budget | $28 Million |
| Type | Expansion |
